Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works.
Rajan Chakrabarty and Randall Martin research fine particulate matter, trying to create a complete picture of the world’s leading cause of environment-related diseases.
Linda J. Pike, the Alumni Endowed Professor of Biochemistry and Molecular Biophysics at the School of Medicine, received a four-year $1.4 million grant from the National Institutes of General Medical Sciences of the National Institutes of Health (NIH).
